Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 2Lymphoma 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

Methotrexate 8Adalimumab 7Etanercept 5tocilizumab 4Rituximab 4tofacitinib 3Abatacept 3olokizumab 2golimumab 2Tumor Necrosis Factor Inhibitors 2Antirheumatic Agents 2upadacitinib 1secukinumab 1sarilumab 1mavrilimumab 1baricitinib 1andecaliximab 1Vitamin D 1Vaccines 1TACI receptor-IgG Fc fragment fusion protein 1Syringes 1Sulfasalazine 1Saline Solution 1Leflunomide 1Hydroxychloroquine 1Herpes Zoster Vaccine 1Folic Acid 1Fish Oils 1Fatty Acids, Omega-3 1Eicosapentaenoic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Arthritis, Rheumatoid × golimumab × Clear all
NCT01715896 2016-10-31

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

MedImmune LLC

Phase 2 Completed
215 enrolled 37 charts

Arthritis, Rheumatoid

NCT00361335 2014-07-29

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Centocor, Inc.

Phase 3 Completed
643 enrolled 14 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡